Andere Sprachen RedHill Biopharma Ltd.

Aktien

A3D9SL

US7574682024

RDHL

Realtime-Estimate Cboe BZX Andere Börsenplätze 17:28:13 26.04.2024			% 5 Tage	% 1. Jan.
0.428 ^USD	+2.82%		-5.97%	-70.89%

24.04.	RedHill Biopharma Ltd. gibt bekannt, dass der erste Patient in die von der US-Regierung unterstützte COVID-19-Studie aufgenommen wurde	CI
08.04.	RedHill Biopharma Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

RedHill Biopharma : Announces First Patient Enrolled in U.S. Government- Supported COVID-19 Study - Form 6-K	24.04.
RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study	24.04.
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights	09.04.
RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	08.04.
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price	03.04.
RedHill Biopharma Ltd. cancelled the transaction announced on March 8, 2023	28.03.
Redhill Biopharma Says Talicia Gets New US Patent to Treat Helicobacter Pylori Infection	11.03.
RedHill Biopharma : Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs - Form 6-K	05.03.
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs	05.03.
U.S. government Selects RedHill Biopharma Ltd.'s Opaganib for Evaluation by BARDA and NIH Countermeasures Programs	05.03.
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis, New Publication	21.02.
Redhill Biopharma Ltd. Announces New Publication of Data from Multiple Experiments in the International Journal of Molecular Sciences	20.02.
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication	20.02.
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL	31.01.
Redhill Biopharma Closes $8 Million Registered Direct Offering of American Depositary Shares	26.01.
RedHill Biopharma Announces $8 Million Registered Direct Offering	26.01.
RedHill Announces New USPTO Patent Grant for Talicia for H. pylori Treatment Through 2042	26.01.
RedHill Biopharma to Seek Acquisitions	26.01.
ADRs Close Higher; Addex Therapeutics Climbs 21%	25.01.
Top Midday Decliners	25.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen RedHill Biopharma Ltd.

Aktien

A3D9SL

US7574682024

RDHL

Andere Sprachen

Filter